Andrew D. Rackear, VP and General Counsel at ENZON PHARMACEUTICALS INC (ENZN), sold 3,766 shares at $6.68 ($25K) on 2011-11-10, disclosed to the SEC on 2011-11-10.
Open-market sale of $25k ENZN by VP and General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.